Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/6/2025

Corticosteroid Use in Common Cold

Introduction to Corticosteroid Risks

  • The European Position Paper on Rhinosinusitis, as referenced by the European medical community, demonstrates that corticosteroids do not provide symptomatic relief for the common cold, with high-quality evidence (Level 1a) 1
  • The common cold is a self-limiting viral illness requiring only symptomatic management, not immunosuppressive therapy, as stated by the American College of Physicians 2

Symptomatic Relief Options

  • For symptomatic relief of common cold, the American Academy of Family Physicians recommends using combination antihistamine-decongestant-analgesic products, which provide significant relief in 1 out of 4 patients 3
  • First-generation antihistamine (brompheniramine) with sustained-release pseudoephedrine can be used for congestion and rhinorrhea, as suggested by the American Academy of Allergy, Asthma, and Immunology 3
  • NSAIDs (ibuprofen 400-800 mg every 6-8 hours) can be used for headache, malaise, and pain, according to the American College of Rheumatology 3, 4
  • Zinc lozenges (≥75 mg/day) can be used only if started within 24 hours of symptom onset, as recommended by the National Institutes of Health 3, 4
  • Nasal saline irrigation can be used for symptom relief, as suggested by the American Academy of Otolaryngology 3

Bacterial Complication Identification

  • Only consider any intervention beyond symptomatic care if at least 3 of the 5 criteria (discolored nasal discharge, severe local facial pain, fever >38°C, "double sickening", elevated inflammatory markers) are present, as advised by the Infectious Diseases Society of America 3, 5
  • Systemic corticosteroids are not recommended for post-viral rhinosinusitis due to lack of benefit and potential harm, according to the European Position Paper on Rhinosinusitis 6

Clinical Practice Guidelines

  • The common cold requires no corticosteroid therapy whatsoever, as stated by the American College of Physicians and the European medical community 1, 2
  • Deflazacort specifically increases infection risk and provides no benefit for cold symptoms, as warned by the FDA 1, 2
  • Reserve antibiotics only for confirmed bacterial complications, not routine cold symptoms, as recommended by the American College of Physicians 2